Originally from Zadar, Croatia, Adela obtained her Master’s degree in Drug Discovery and Safety from the Vrije Universiteit Amsterdam in The Netherlands in 2022. Her master’s thesis focused on synthesizing peptides as inhibitors of the β-catenin protein of the Wnt-signalling pathway.

In 2023, Adela joined the Dikic and Dötsch group as a shared PhD student through the IMPRS program at the Max Planck Institute of Cellular Biophysics, in Frankfurt. Her doctoral research is based on proximity-induced protein degradation and its biophysical characterization.